Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 532

1.

Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization.

Pereira AC, Miyakawa AA, Lopes NH, Soares PR, de Oliveira SA, Cesar LA, Ramires JF, Hueb W, Krieger JE.

Thromb Res. 2007;121(1):25-32. Epub 2007 Jul 2.

PMID:
17604826
2.

C677T polymorphism of the methylenetetrahydrofolate reductase gene is a risk factor of adverse events after coronary revascularization.

Botto N, Andreassi MG, Rizza A, Berti S, Bevilacqua S, Federici C, Palmieri C, Glauber M, Biagini A.

Int J Cardiol. 2004 Sep;96(3):341-5.

PMID:
15301885
3.
4.

Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).

Freitas AI, Mendonça I, Guerra G, Brión M, Reis RP, Carracedo A, Brehm A.

Thromb Res. 2008;122(5):648-56. doi: 10.1016/j.thromres.2008.02.005. Epub 2008 Apr 1.

PMID:
18384842
5.

Impact of number of vessels disease on outcome of patients with stable coronary artery disease: 5-year follow-up of the Medical, Angioplasty, and bypass Surgery study (MASS).

Lopes NH, Paulitsch Fda S, Gois AF, Pereira AC, Stolf NA, Dallan LO, Ramires JA, Hueb WA.

Eur J Cardiothorac Surg. 2008 Mar;33(3):349-54. doi: 10.1016/j.ejcts.2007.11.025. Epub 2008 Jan 30.

PMID:
18249128
6.

C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.

Yilmaz H, Isbir S, Agachan B, Ergen A, Farsak B, Isbir T.

Cell Biochem Funct. 2006 Jan-Feb;24(1):87-90.

PMID:
15648053
7.

Methylenetetrahydrofolate reductase gene C677T polymorphism, homocysteine, vitamin B12, and DNA damage in coronary artery disease.

Andreassi MG, Botto N, Cocci F, Battaglia D, Antonioli E, Masetti S, Manfredi S, Colombo MG, Biagini A, Clerico A.

Hum Genet. 2003 Feb;112(2):171-7. Epub 2002 Nov 13.

PMID:
12522558
8.

Effect of the MTHFR C677T and A1298C polymorphisms on survival in patients with advanced CKD and ESRD: a prospective study.

Jamison RL, Shih MC, Humphries DE, Guarino PD, Kaufman JS, Goldfarb DS, Warren SR, Gaziano JM, Lavori P; Veterans Affairs Site Investigators.

Am J Kidney Dis. 2009 May;53(5):779-89. doi: 10.1053/j.ajkd.2008.12.023. Epub 2009 Mar 9.

PMID:
19272686
9.

Effect of MTHFR C677T genotype on survival in type 2 diabetes patients with end-stage diabetic nephropathy.

Böger CA, Stubanus M, Haak T, Götz AK, Christ J, Hoffmann U, Riegger GA, Krämer BK.

Nephrol Dial Transplant. 2007 Jan;22(1):154-62. Epub 2006 Sep 27.

PMID:
17005529
10.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population.

Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, Rausei S, D'ugo D, Magistrelli P, Villari P, Van Duijn CM, Ricciardi G.

Biomarkers. 2007 Nov-Dec;12(6):635-44.

PMID:
17972183
11.

Higher incidence of death in multi-vessel coronary artery disease patients associated with polymorphisms in chromosome 9p21.

Gioli-Pereira L, Santos PC, Ferreira NE, Hueb WA, Krieger JE, Pereira AC.

BMC Cardiovasc Disord. 2012 Aug 2;12:61. doi: 10.1186/1471-2261-12-61.

12.

Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.

Kerkeni M, Addad F, Chauffert M, Myara A, Gerhardt M, Chevenne D, Trivin F, Farhat MB, Miled A, Maaroufi K.

Ann Clin Biochem. 2006 May;43(Pt 3):200-6.

PMID:
16704755
13.

5,10-Methylenetetrahydrofolate reductase C677T gene polymorphism in Behcet's patients with or without ocular involvement.

Ozkul Y, Evereklioglu C, Borlu M, Taheri S, Calis M, Dündar M, Ilhan O.

Br J Ophthalmol. 2005 Dec;89(12):1634-7.

14.

An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease.

Dedoussis GV, Panagiotakos DB, Pitsavos C, Chrysohoou C, Skoumas J, Choumerianou D, Stefanadis C; ATTICA Study Group.

Int J Cardiol. 2005 Apr 28;100(3):409-14.

PMID:
15837084
15.

Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS).

Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, O'Neill WW, Wijns W, Serruys PW.

Am Heart J. 2005 Mar;149(3):512-9.

PMID:
15864241
16.

An association of 5,10-methylenetetrahydrofolate reductase (MTHFR) gene polymorphism and common carotid atherosclerosis.

Kawamoto R, Kohara K, Tabara Y, Miki T, Doi T, Tokunaga H, Konishi I.

J Hum Genet. 2001;46(9):506-10.

PMID:
11558898
17.

Hyperhomocysteinemia and mortality after coronary artery bypass grafting.

Girelli D, Martinelli N, Olivieri O, Pizzolo F, Friso S, Faccini G, Bozzini C, Tenuti I, Lotto V, Villa G, Guarini P, Trabetti E, Pignatti PF, Mazzucco A, Corrocher R.

PLoS One. 2006 Dec 20;1:e83.

18.

Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).

Husemoen LL, Thomsen TF, Fenger M, Jørgensen HL, Jørgensen T.

Genet Epidemiol. 2003 May;24(4):322-30.

PMID:
12687650
19.
20.

Supplemental Content

Support Center